Cargando…

Combination Therapy of Ursodeoxycholic Acid and Corticosteroids for Primary Biliary Cirrhosis with Features of Autoimmune Hepatitis: A Meta-Analysis

A meta-analysis was performed of RCTs comparing therapies that combine UDCA and corticosteroids with UDCA monotherapy. In this paper, we found that the combination therapy of UDCA and corticosteroids was more effective for PBC-AIH.

Detalles Bibliográficos
Autores principales:	Zhang, Yan, Lu, Jie, Dai, Weiqi, Wang, Fan, Shen, Miao, Yang, Jing, Zhu, Rong, Zhang, Huawei, Chen, Kan, Cheng, Ping, He, Lei, Wang, Chengfen, Xu, Ling, Zhou, Yingqun, Guo, Chuanyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867832/ https://www.ncbi.nlm.nih.gov/pubmed/24369456 http://dx.doi.org/10.1155/2013/490731

Ejemplares similares

Combination therapy of ursodeoxycholic acid and budesonide for PBC–AIH overlap syndrome: a meta-analysis
por: Zhang, Huawei, et al.
Publicado: (2015)

Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis
por: Zhang, Yan, et al.
Publicado: (2015)

Hydrogen Sulfide Ameliorates Ischemia/Reperfusion-Induced Hepatitis by Inhibiting Apoptosis and Autophagy Pathways
por: Cheng, Ping, et al.
Publicado: (2014)

Corrigendum to “Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy”
por: Shen, Miao, et al.
Publicado: (2016)

Ethyl Pyruvate Pretreatment Attenuates Concanavalin A-Induced Autoimmune Hepatitis in Mice
por: Shen, Miao, et al.
Publicado: (2014)

Hydrogen sulfide, a potential novel drug, attenuates concanavalin A-induced hepatitis
por: Cheng, Ping, et al.
Publicado: (2014)

Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in Mice
por: Wang, Chengfen, et al.
Publicado: (2015)

Protective Effects of Astaxanthin on ConA-Induced Autoimmune Hepatitis by the JNK/p-JNK Pathway-Mediated Inhibition of Autophagy and Apoptosis
por: Li, Jingjing, et al.
Publicado: (2015)

15-Deoxy-γ12,14-prostaglandin J2 Reduces Liver Impairment in a Model of ConA-Induced Acute Hepatic Inflammation by Activation of PPARγ and Reduction in NF-κB Activity
por: Chen, Kan, et al.
Publicado: (2014)

Erratum to “15-Deoxy-γ12,14-prostaglandin J2 Reduces Liver Impairment in a Model of ConA-Induced Acute Hepatic Inflammation by Activation of PPARγ and Reduction in NF-κB Activity”
por: Chen, Kan, et al.
Publicado: (2014)

A decline of LAMP- 2 predicts ursodeoxycholic acid response in primary biliary cirrhosis
por: Wang, Lu, et al.
Publicado: (2015)

Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis
por: Yin, Qin, et al.
Publicado: (2015)

K-ras Mutational Status in Cytohistological Tissue as a Molecular Marker for the Diagnosis of Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Yang, Jing, et al.
Publicado: (2014)

N-Acetylcysteine Attenuates Ischemia-Reperfusion-Induced Apoptosis and Autophagy in Mouse Liver via Regulation of the ROS/JNK/Bcl-2 Pathway
por: Wang, Chengfen, et al.
Publicado: (2014)

The Synergistic In Vitro and In Vivo Antitumor Effect of Combination Therapy with Salinomycin and 5-Fluorouracil against Hepatocellular Carcinoma
por: Wang, Fan, et al.
Publicado: (2014)

Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis
por: YANG, JING, et al.
Publicado: (2015)

Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis
por: Zhu, Rong, et al.
Publicado: (2014)

Protective Effect of Astaxanthin on Liver Fibrosis through Modulation of TGF-β1 Expression and Autophagy
por: Shen, Miao, et al.
Publicado: (2014)

A meta-analysis of ursodeoxycholic acid therapy versus combination therapy with corticosteroids for PBC-AIH-overlap syndrome: evidence from 97 monotherapy and 117 combinations
por: Zhang, Huawei, et al.
Publicado: (2015)

Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy
por: Shen, Miao, et al.
Publicado: (2013)

Ursodeoxycholic Acid Improves Bilirubin but Not Albumin in Primary Biliary Cirrhosis: Further Evidence for Nonefficacy
por: Tsochatzis, Emmanuel A., et al.
Publicado: (2013)

A Systems Model for Ursodeoxycholic Acid Metabolism in Healthy and Patients With Primary Biliary Cirrhosis
por: Zuo, P, et al.
Publicado: (2016)

Incipient primary biliary cirrhosis/autoimmune hepatitis overlap or hepatitic form of primary biliary cirrhosis: a case report
por: Minz, Ranjana W, et al.
Publicado: (2009)

Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis
por: Torisu, Yuichi, et al.
Publicado: (2017)

The Association between Bile Salt Export Pump Single-Nucleotide Polymorphisms and Primary Biliary Cirrhosis Susceptibility and Ursodeoxycholic Acid Response
por: Chen, Rui-rui, et al.
Publicado: (2014)

Notch Signaling Coordinates Progenitor Cell-Mediated Biliary Regeneration Following Partial Hepatectomy
por: Lu, Jie, et al.
Publicado: (2016)

Treatment of primary biliary cirrhosis with ursodeoxycholic acid combined with traditional Chinese medicine: A protocol for systematic review and meta analysis
por: Chen, Xing, et al.
Publicado: (2020)

Primary Biliary Cirrhosis Is a Generalized Autoimmune Epithelitis
por: Gao, Jun, et al.
Publicado: (2015)

Association of an overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis with cytomegalovirus infection
por: Toyoda-Akui, Megumi, et al.
Publicado: (2011)

Xanthoma Striatum Palmare in a Patient of Primary Biliary Cirrhosis with Autoimmune Hepatitis
por: Yang, Min-Young, et al.
Publicado: (2017)

Primary biliary cirrhosis and autoimmunity: molecules and mimics
por: Gershwin, M Eric
Publicado: (2012)

Primary Biliary Cirrhosis Overlapping with Autoimmune Hepatitis in an HIV-Infected Patient on Antiretroviral Therapy
por: Caplan, Margaret, et al.
Publicado: (2013)

The autoimmunity of primary biliary cirrhosis and the clonal selection theory
por: Selmi, Carlo, et al.
Publicado: (2010)

Ursodeoxycholic Acid Influences the Expression of p27(kip1) but Not FoxO1 in Patients with Non-Cirrhotic Primary Biliary Cirrhosis
por: Milkiewicz, Malgorzata, et al.
Publicado: (2014)

Familial occurrence of autoimmune liver disease with overlapping features of primary biliary cholangitis and autoimmune hepatitis in a mother and her daughter
por: Omori, Kaoru, et al.
Publicado: (2016)

Visceral Leishmaniasis Mimicking Autoimmune Hepatitis, Primary Biliary Cirrhosis, and Systemic Lupus Erythematosus Overlap
por: Tunccan, Ozlem Guzel, et al.
Publicado: (2012)

Successful Pregnancy in Autoimmune Hepatitis/Primary Biliary Cirrhosis Overlap Syndrome: A Case Report
por: Mitra, Subarna, et al.
Publicado: (2012)

Protective Effects of Necrostatin-1 against Concanavalin A-Induced Acute Hepatic Injury in Mice
por: Zhou, Yingqun, et al.
Publicado: (2013)

Predictive Model of Ursodeoxycholic Acid Treatment Response in Primary Biliary Cholangitis
por: Shu, Yanyun, et al.
Publicado: (2021)

Autoimmune Hepatitis-related Cirrhosis: Clinical Features and Effectiveness of Immunosuppressive Treatment in Chinese Patients
por: Li, Yan-Ni, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_20hp2dgnhug3a7qm7leiehrlpm